[<sup>153</sup>Sm]Samarium-labeled FAPI-46 radioligand therapy in a patient with lung metastases of a sarcoma.

导出 OA

翻译打印收藏纠错

作者： Clemens,Kratochwil ^[1] ; Frederik L,Giesel ^[2] ; Hendrik,Rathke ^[2] ; Rebecca,Fink ^[2] ; Katharina,Dendl ^[2] ; Jürgen,Debus ^[3] ; Walter,Mier ^[2] ; Dirk,Jäger ^[4] ; Thomas,Lindner ^[2] ; Uwe,Haberkorn ^[2]

作者单位： Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany. Clemens.Kratochwil@med.uni-heidelberg.de. ^[1] Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany. ^[2] Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany. ^[3] Department of Medical Oncology, Heidelberg University Hospital and National Center for Tumor Diseases (NCT), Heidelberg, Germany. ^[4] Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany. ^[5] Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany. ^[6]

主题词人类(Humans);肺肿瘤(Lung Neoplasms);喹啉类(Quinolines);钐(Samarium);肉瘤(Sarcoma)

DOI 10.1007/s00259-021-05273-8

PMID 33728499

发布时间 2021-10-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交